Showing results (1-10 of 374) with videos related to
Sort By:
Pageof 38
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 1998
Staphylococcus epidermidis: emerging resistance and need for alternative agentsI Raad, A Alrahwan, K RolstonEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1996
Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patientsG Bodey, D Abi-Said, K Rolston, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1998
Clinical and radiological features of pulmonary disease caused by rapidly growing mycobacteria in cancer patientsK Jacobson, R Garcia, H Libshitz, et al.The Journal of Antimicrobial Chemotherapy|January 5, 2008
The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancerS Youssef, R Hachem, R F Chemaly, et al.Antimicrobial Agents and Chemotherapy|October 16, 2001
Treatment of vancomycin-resistant enterococcal infections in the immunocompromised host: quinupristin-dalfopristin in combination with minocyclineI Raad, R Hachem, H Hanna, et al.Infection Control and Hospital Epidemiology|April 20, 2001
Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours?I Raad, H A Hanna, A Awad, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 22, 2007
Sources and outcome of bloodstream infections in cancer patients: the role of central venous cathetersI Raad, R Hachem, H Hanna, et al.Journal of Clinical Microbiology|December 8, 2006
blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC programH Aboufaycal, H S Sader, K Rolston, et al.Leukemia & Lymphoma|June 28, 2001
Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemiaR V Fleming, H M Kantarjian, R Husni, et al.Pageof 38